Avanguard CRO

Therapeutic Expertise

Specialized Experience Across Key Therapeutic Areas

We bring focused operational knowledge to each therapeutic area we support, understanding the unique regulatory, protocol, and site management demands each one presents.

Avanguard specializes in Phase I studies and maintains deep experience across later phases in the areas below.

Cardiology

Cardiovascular trials require precise endpoint management, rigorous safety monitoring, and experience with complex patient populations. We bring operational discipline to every phase of cardiac development programs.

  • Cardiac safety monitoring and ECG management
  • MACE endpoint adjudication support
  • Experience with device-drug combination trials
  • FDA and EMA cardiovascular guidance alignment

Central Nervous System

CNS trials present unique challenges in patient recruitment, endpoint sensitivity, and long-term follow-up. Our teams are experienced in the operational complexity these programs demand.

  • Neurological and psychiatric endpoint management
  • Rater training and inter-rater reliability programs
  • Patient retention strategies for long-duration studies
  • Regulatory experience with CNS-specific guidance documents

Rare Diseases

Rare disease programs require creative site strategies, deep patient advocacy engagement, and regulatory expertise in orphan drug pathways. We understand the urgency and complexity these sponsors face.

  • Orphan drug designation and regulatory strategy
  • Small population trial design considerations
  • Patient registry and natural history study support
  • Expanded access and compassionate use programs

Immunology

Immunology and inflammation programs span a broad range of indications and require expertise in biomarker-driven endpoints and complex dosing regimens. We support sponsors from first-in-human through late-phase development.

  • Biomarker sample management and central lab coordination
  • Immunogenicity assessment planning
  • Experience with biologics and biosimilar programs
  • Autoimmune and inflammatory indication expertise

Infectious Disease

Infectious disease trials often operate under accelerated timelines and heightened regulatory scrutiny. Our teams are experienced in adaptive trial designs and the operational demands of outbreak-driven programs.

  • Adaptive and platform trial operational support
  • Vaccine and antiviral program experience
  • Rapid site activation and enrollment strategies
  • FDA Emergency Use Authorization process familiarity

Metabolic Disorders

Metabolic programs including diabetes, obesity, and NASH require long-term follow-up, complex endpoints, and broad site networks. We bring the operational infrastructure to manage these demanding studies.

  • Long-term outcomes trial management
  • Metabolic and hepatic endpoint expertise
  • Central imaging and biopsy coordination
  • Diabetes, obesity, and NASH indication experience

Respiratory

Respiratory trials require specialized spirometry oversight, patient-reported outcome management, and experience with both acute and chronic disease programs. We support sponsors across the full respiratory development spectrum.

  • Spirometry and pulmonary function test oversight
  • Patient-reported outcome instrument management
  • Asthma, COPD, and ILD indication experience
  • Inhaled and biologic therapy trial expertise

Working in a therapeutic area not listed here?

Reach out and tell us about your program. We are happy to discuss whether we are the right fit.